| Age . | Mean (SD), Range . | 43 (13) . | 19-75 . |
|---|---|---|---|
| . | . | n . | % . |
| Diagnosis | Anaplastic astrocytoma | 10 | 14 |
| Anaplastic ependymoma | 7 | 10 | |
| Anaplastic hemangiopericytoma | 1 | 1 | |
| Anaplastic oligodendroglioma | 6 | 8 | |
| Anaplastic pleomorphic xanthoastrocytoma | 2 | 3 | |
| Astrocytoma | 5 | 7 | |
| Diffuse midline glioma | 2 | 3 | |
| Dysembryoplastic neuroepithelial tumor | 1 | 1 | |
| Ependymoma | 7 | 10 | |
| Glioblastoma | 14 | 20 | |
| Gliosarcoma | 1 | 1 | |
| High-grade neuroepithelial tumor | 1 | 1 | |
| Medulloblastoma | 2 | 3 | |
| Myxopapillary ependymoma | 4 | 6 | |
| Oligodendroglioma | 1 | 1 | |
| Papillary tumor of pineal region | 1 | 1 | |
| Pilocytic astrocytoma | 3 | 4 | |
| Pleomorphic xanthoastrocytoma | 1 | 1 | |
| No tissue diagnosis | 2 | 3 | |
| Number of treatments | 0 | 27 | 38 |
| 1 | 24 | 34 | |
| ≥2 | 20 | 28 | |
| Current treatment phase | Active treatment | 15 | 21 |
| Surveillance | 56 | 79 | |
| Number of surgeries | 0 | 2 | 3 |
| 1 | 39 | 55 | |
| 2 | 19 | 27 | |
| ≥3 | 11 | 15 | |
| Original surgery extent | Biopsy | 17 | 24 |
| Subtotal resection | 29 | 41 | |
| Gross total resection | 18 | 25 | |
| Resection NOS | 5 | 7 | |
| Number of recurrences | 0 | 41 | 58 |
| 1 | 12 | 17 | |
| ≥2 | 18 | 25 | |
| Tumor location | Brain | 52 | 73 |
| Brain + spine | 6 | 8 | |
| Spine | 13 | 18 |
| Age . | Mean (SD), Range . | 43 (13) . | 19-75 . |
|---|---|---|---|
| . | . | n . | % . |
| Diagnosis | Anaplastic astrocytoma | 10 | 14 |
| Anaplastic ependymoma | 7 | 10 | |
| Anaplastic hemangiopericytoma | 1 | 1 | |
| Anaplastic oligodendroglioma | 6 | 8 | |
| Anaplastic pleomorphic xanthoastrocytoma | 2 | 3 | |
| Astrocytoma | 5 | 7 | |
| Diffuse midline glioma | 2 | 3 | |
| Dysembryoplastic neuroepithelial tumor | 1 | 1 | |
| Ependymoma | 7 | 10 | |
| Glioblastoma | 14 | 20 | |
| Gliosarcoma | 1 | 1 | |
| High-grade neuroepithelial tumor | 1 | 1 | |
| Medulloblastoma | 2 | 3 | |
| Myxopapillary ependymoma | 4 | 6 | |
| Oligodendroglioma | 1 | 1 | |
| Papillary tumor of pineal region | 1 | 1 | |
| Pilocytic astrocytoma | 3 | 4 | |
| Pleomorphic xanthoastrocytoma | 1 | 1 | |
| No tissue diagnosis | 2 | 3 | |
| Number of treatments | 0 | 27 | 38 |
| 1 | 24 | 34 | |
| ≥2 | 20 | 28 | |
| Current treatment phase | Active treatment | 15 | 21 |
| Surveillance | 56 | 79 | |
| Number of surgeries | 0 | 2 | 3 |
| 1 | 39 | 55 | |
| 2 | 19 | 27 | |
| ≥3 | 11 | 15 | |
| Original surgery extent | Biopsy | 17 | 24 |
| Subtotal resection | 29 | 41 | |
| Gross total resection | 18 | 25 | |
| Resection NOS | 5 | 7 | |
| Number of recurrences | 0 | 41 | 58 |
| 1 | 12 | 17 | |
| ≥2 | 18 | 25 | |
| Tumor location | Brain | 52 | 73 |
| Brain + spine | 6 | 8 | |
| Spine | 13 | 18 |
Abbreviations: NOS, not otherwise specified; SD, standard deviation.
| Age . | Mean (SD), Range . | 43 (13) . | 19-75 . |
|---|---|---|---|
| . | . | n . | % . |
| Diagnosis | Anaplastic astrocytoma | 10 | 14 |
| Anaplastic ependymoma | 7 | 10 | |
| Anaplastic hemangiopericytoma | 1 | 1 | |
| Anaplastic oligodendroglioma | 6 | 8 | |
| Anaplastic pleomorphic xanthoastrocytoma | 2 | 3 | |
| Astrocytoma | 5 | 7 | |
| Diffuse midline glioma | 2 | 3 | |
| Dysembryoplastic neuroepithelial tumor | 1 | 1 | |
| Ependymoma | 7 | 10 | |
| Glioblastoma | 14 | 20 | |
| Gliosarcoma | 1 | 1 | |
| High-grade neuroepithelial tumor | 1 | 1 | |
| Medulloblastoma | 2 | 3 | |
| Myxopapillary ependymoma | 4 | 6 | |
| Oligodendroglioma | 1 | 1 | |
| Papillary tumor of pineal region | 1 | 1 | |
| Pilocytic astrocytoma | 3 | 4 | |
| Pleomorphic xanthoastrocytoma | 1 | 1 | |
| No tissue diagnosis | 2 | 3 | |
| Number of treatments | 0 | 27 | 38 |
| 1 | 24 | 34 | |
| ≥2 | 20 | 28 | |
| Current treatment phase | Active treatment | 15 | 21 |
| Surveillance | 56 | 79 | |
| Number of surgeries | 0 | 2 | 3 |
| 1 | 39 | 55 | |
| 2 | 19 | 27 | |
| ≥3 | 11 | 15 | |
| Original surgery extent | Biopsy | 17 | 24 |
| Subtotal resection | 29 | 41 | |
| Gross total resection | 18 | 25 | |
| Resection NOS | 5 | 7 | |
| Number of recurrences | 0 | 41 | 58 |
| 1 | 12 | 17 | |
| ≥2 | 18 | 25 | |
| Tumor location | Brain | 52 | 73 |
| Brain + spine | 6 | 8 | |
| Spine | 13 | 18 |
| Age . | Mean (SD), Range . | 43 (13) . | 19-75 . |
|---|---|---|---|
| . | . | n . | % . |
| Diagnosis | Anaplastic astrocytoma | 10 | 14 |
| Anaplastic ependymoma | 7 | 10 | |
| Anaplastic hemangiopericytoma | 1 | 1 | |
| Anaplastic oligodendroglioma | 6 | 8 | |
| Anaplastic pleomorphic xanthoastrocytoma | 2 | 3 | |
| Astrocytoma | 5 | 7 | |
| Diffuse midline glioma | 2 | 3 | |
| Dysembryoplastic neuroepithelial tumor | 1 | 1 | |
| Ependymoma | 7 | 10 | |
| Glioblastoma | 14 | 20 | |
| Gliosarcoma | 1 | 1 | |
| High-grade neuroepithelial tumor | 1 | 1 | |
| Medulloblastoma | 2 | 3 | |
| Myxopapillary ependymoma | 4 | 6 | |
| Oligodendroglioma | 1 | 1 | |
| Papillary tumor of pineal region | 1 | 1 | |
| Pilocytic astrocytoma | 3 | 4 | |
| Pleomorphic xanthoastrocytoma | 1 | 1 | |
| No tissue diagnosis | 2 | 3 | |
| Number of treatments | 0 | 27 | 38 |
| 1 | 24 | 34 | |
| ≥2 | 20 | 28 | |
| Current treatment phase | Active treatment | 15 | 21 |
| Surveillance | 56 | 79 | |
| Number of surgeries | 0 | 2 | 3 |
| 1 | 39 | 55 | |
| 2 | 19 | 27 | |
| ≥3 | 11 | 15 | |
| Original surgery extent | Biopsy | 17 | 24 |
| Subtotal resection | 29 | 41 | |
| Gross total resection | 18 | 25 | |
| Resection NOS | 5 | 7 | |
| Number of recurrences | 0 | 41 | 58 |
| 1 | 12 | 17 | |
| ≥2 | 18 | 25 | |
| Tumor location | Brain | 52 | 73 |
| Brain + spine | 6 | 8 | |
| Spine | 13 | 18 |
Abbreviations: NOS, not otherwise specified; SD, standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
